Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP

NCT00482937 is registered in ClinicalTrials.gov with Nile Therapeutics as lead sponsor.

NCT NCT00482937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00482937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP
Lead sponsor
Nile Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
May 31, 2007
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive